UCL ACED Lecture Series

Hosted by Prof. Yoryos Lyratzopoulos, UCL Epidemiology of Cancer Healthcare & Outcomes research group. 

In this lecture Professor Etzioni will summarise her research on statistical methods to support the estimation of overdiagnosis in screening-detectable cancers. She will explain why studies yield a diversity of estimates and review work designed to reconcile discordant results. She will also consider the notion of risk-stratified screening from a statistical perspective and examine the likely gain that may (or may not) be attainable via risk-stratified screening programmes.

Dr Etzioni is a Distinguished Scientist in the Center for Early Detection Advanced Research at the Knight Cancer Institute and a Full Member in the Public Health Sciences Division at Fred Hutch Cancer Research Center, Seattle. She grew up in South Africa and received her PhD in Statistics from Carnegie Mellon University, Pittsburgh, Pennsylvania. Her research uses statistical and simulation models to address evidence gaps that inevitably arise in medical decision making and cancer policy development.

She is a member the American Cancer Society’s Screening Guideline Development Panel and the National Comprehensive Cancer Network’s Prostate Cancer Early Detection Panel. She has also served on the American Urology Association’s Prostate Cancer Screening Guidelines Committee. She is a Fellow of the American Statistical Association and current Chair of its Health Policy Statistics Section.
 

The International Alliance for Cancer Early Detection (ACED) is a new £55 million partnership between Cancer Research UK, the Canary Center at Stanford University, the University of Cambridge, the Knight Cancer Institute at OHSU, University College London and the University of Manchester.